Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Prayasee Baruah, Grace Basumatary, Semen O. Yesylevskyy, Kripamoy Aguan, Ghanashyam Bez & Sivaprasad Mitra. (2019) Novel coumarin derivatives as potent acetylcholinesterase inhibitors: insight into efficacy, mode and site of inhibition. Journal of Biomolecular Structure and Dynamics 37:7, pages 1750-1765.
Read now
Read now
Wei-Na Yang, Xiao-Dan Hu, Hua Han, Li-Li Shi, Gai-Feng Feng, Yong Liu & Yi-Hua Qian. (2014) The effects of valsartan on cognitive deficits induced by aluminum trichloride and d-galactose in mice. Neurological Research 36:7, pages 651-658.
Read now
Read now
Lucy Nelson, Naji Tabet, Cassie Richardson & Paul Gard. (2013) Antihypertensives, angiotensin, glucose and Alzheimer’s disease. Expert Review of Neurotherapeutics 13:5, pages 477-482.
Read now
Read now
Recep Sutcu, Aynur Kirbas, Serkan Kirbas, Suleyman Kutluhan & Namik Delibas. (2012) Effects of lisinopril on NMDA receptor subunits 2A and 2B levels in the hippocampus of rats with l-NAME-induced hypertension. Journal of Receptors and Signal Transduction 32:5, pages 279-284.
Read now
Read now
Jerry J Buccafusco. (2009) Emerging cognitive enhancing drugs. Expert Opinion on Emerging Drugs 14:4, pages 577-589.
Read now
Read now
Articles from other publishers (23)
Lilian Calderón-Garcidueñas, Ricardo Torres-Jardón, Maricela Franco-Lira, Randy Kulesza, Angélica González-Maciel, Rafael Reynoso-Robles, Rafael Brito-Aguilar, Berenice García-Arreola, Paula Revueltas-Ficachi, Juana Adriana Barrera-Velázquez, Griselda García-Alonso, Edgar García-Rojas, Partha S. Mukherjee & Ricardo Delgado-Chávez. (2020) Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer’s and Parkinson’s Diseases in Young Urbanites Exposed to Air Pollution. Journal of Alzheimer's Disease 78:2, pages 479-503.
Crossref
Crossref
Ehab Farag, Daniel I. Sessler, Zeyd Ebrahim, Andrea Kurz, Joseph Morgan, Sanchit Ahuja, Kamal Maheshwari & D. John Doyle. (2017) The renin angiotensin system and the brain: New developments. Journal of Clinical Neuroscience 46, pages 1-8.
Crossref
Crossref
Xinwu Huang, Guozhou Lu, Guochun Li, Hua Li, Beihua Li, Jiazhen Yin & Shousong Cao. (2017) Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia. Frontiers in Neuroscience 11.
Crossref
Crossref
Lucy Nelson & Naji Tabet. (2015) Slowing the progression of Alzheimer’s disease; what works?. Ageing Research Reviews 23, pages 193-209.
Crossref
Crossref
Walther Bild, Lucian Hritcu, Cristinel Stefanescu & Alin Ciobica. (2013) Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus. Progress in Neuro-Psychopharmacology and Biological Psychiatry 43, pages 79-88.
Crossref
Crossref
Marie-Odile Guimond & Nicole Gallo-Payet. (2012) The Angiotensin II Type 2 Receptor in Brain Functions: An Update. International Journal of Hypertension 2012, pages 1-18.
Crossref
Crossref
Santoshkumar Tota, Pradeep Kumar Kamat, Gunjan Saxena, Kashif Hanif, Abul Kalam Najmi & Chandishwar Nath. (2012) Central angiotensin converting enzyme facilitates memory impairment in intracerebroventricular streptozotocin treated rats. Behavioural Brain Research 226:1, pages 317-330.
Crossref
Crossref
Alvin V. TerryJr.Jr., Patrick M. Callahan, Brandon Hall & Scott J. Webster. (2011) Alzheimer's disease and age-related memory decline (preclinical). Pharmacology Biochemistry and Behavior 99:2, pages 190-210.
Crossref
Crossref
Amit Jasvant Shah, Shaoyong Su, Emir Veledar, James Douglas Bremner, Felicia C. Goldstein, Rachel Lampert, Jack Goldberg & Viola Vaccarino. (2011) Is Heart Rate Variability Related to Memory Performance in Middle-Aged Men?. Psychosomatic Medicine 73:6, pages 475-482.
Crossref
Crossref
Ryuichi Morishita. (2010) How to evaluate real-world medicine in a Japanese population: important lessons from the JIKEI, CASE-J, KYOTO and VART studies. Hypertension Research 34:1, pages 33-35.
Crossref
Crossref
Paul R Gard. (2010) Non-adherence to antihypertensive medication and impaired cognition: which comes first?. International Journal of Pharmacy Practice 18:5, pages 252-259.
Crossref
Crossref
Doris Albrecht. (2010) Physiological and pathophysiological functions of different angiotensins in the brain. British Journal of Pharmacology 159:7, pages 1392-1401.
Crossref
Crossref
John Kelly. 2010. Principles of CNS Drug Development. Principles of CNS Drug Development
245
286
.
Patrick G. Kehoe, Scott Miners & Seth Love. (2009) Angiotensins in Alzheimer's disease – friend or foe?. Trends in Neurosciences 32:12, pages 619-628.
Crossref
Crossref
Trisha A. Jenkins. (2008) Effect of angiotensin-related antihypertensives on brain neurotransmitter levels in rats. Neuroscience Letters 444:2, pages 186-189.
Crossref
Crossref
D. Kumaran, M. Udayabanu, M. Kumar, R. Aneja & A. Katyal. (2008) Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats. Neuroscience 155:3, pages 626-639.
Crossref
Crossref
Ivy O. Poon. (2012) Effects of Antihypertensive Drug Treatment on the Risk of Dementia and Cognitive Impairment. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28:3, pages 366-375.
Crossref
Crossref
Ryuichi MORISHITA. (2008) Aegis against Stroke and Dementia by Angiotensin Type 1 Receptor Blockers: New Beneficial Aspects. Hypertension Research 31:1, pages 1-3.
Crossref
Crossref
Fernando Augusto Oliveira, Priscila Elisa Silveira, Miguel José Lopes, Christopher Kushmerick & Lígia Araujo Naves. (2007) Angiotensin II increases evoked release at the frog neuromuscular junction through a receptor sensitive to A779. Brain Research 1175, pages 48-53.
Crossref
Crossref
Kun Zou, Haruyasu Yamaguchi, Hiroyasu Akatsu, Takaaki Sakamoto, Mihee Ko, Kazushige Mizoguchi, Jian-Sheng Gong, Wenxin Yu, Takayuki Yamamoto, Kenji Kosaka, Katsuhiko Yanagisawa & Makoto Michikawa. (2007)
Angiotensin-Converting Enzyme Converts Amyloid β-Protein 1–42 (Aβ
1–42
) to Aβ
1–40
, and Its Inhibition Enhances Brain Aβ Deposition
. The Journal of Neuroscience 27:32, pages 8628-8635.
Crossref
Crossref
G.K. Aulakh, R.K. Sodhi & M. Singh. (2007) An update on non-peptide angiotensin receptor antagonists and related RAAS modulators. Life Sciences 81:8, pages 615-639.
Crossref
Crossref
Jana Tchekalarova & Doris Albrecht. (2007) Angiotensin II suppresses long-term depression in the lateral amygdala of mice via L-type calcium channels. Neuroscience Letters 415:1, pages 68-72.
Crossref
Crossref
O. von Bohlen und Halbach & D. Albrecht. (2006) The CNS renin-angiotensin system. Cell and Tissue Research 326:2, pages 599-616.
Crossref
Crossref